Back
Apellis Pharmaceuticals, Inc. Vs. Braze, Inc. Industry Stock Comparison
Buy
57
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$24.97
Seasonality Move:
7.92%
Buy
60
BRZE
Braze, Inc.
Last Price:
$34.84
Seasonality Move:
-12.95%
Buy
57
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.97. The Score for APLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Braze, Inc. (BRZE)
is a Buy
Is Braze, Inc. a Buy, Sell or Hold?
-
The current Braze, Inc. [BRZE] share price is $34.93. The Score for BRZE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
BRZE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $24.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
BRZE Stock Price Chart
What is Braze, Inc.'s stock price today?
-
The Braze, Inc. share price today is $34.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRZE is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 67.36 | Buy |
| Chaikin Money Flow: | -208746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.29 - 22.81) | Buy |
| Bollinger Bands (100): | (20.75 - 26.93) | Buy |
BRZE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 72.94 | Buy |
| Chaikin Money Flow: | -2469560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.12 | Buy |
| 20-day SMA: | 21.44 | Buy |
| 50-day SMA: | 23.06 | Buy |
| 200-day SMA: | 21.92 | Buy |
| 8-day EMA: | 23.44 | Buy |
| 20-day EMA: | 22.39 | Buy |
| 50-day EMA: | 22.63 | Buy |
| 200-day EMA: | 24.24 | Buy |
BRZE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.33 | Buy |
| 20-day SMA: | 29.22 | Buy |
| 50-day SMA: | 28.29 | Buy |
| 200-day SMA: | 30.21 | Buy |
| 8-day EMA: | 31.96 | Buy |
| 20-day EMA: | 30.09 | Buy |
| 50-day EMA: | 29.05 | Buy |
| 200-day EMA: | 30.83 | Buy |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Braze, Inc. Earnings Growth & BRZE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.06 per share, an increase this year of $0.37 per share, and an increase next year of $0.31 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Braze, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||